BI 44370 TA

· Boehringer Ingelheim

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for BI 44370 TA, covering 2014-08-13 to 2014-11-24. Get the full timeline:

Most recent: Clinical Trial Update: BI 44370 TA in Acute Migraine Attack [Phase 2]